Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 3/20 | 0.40 |
| ▸ | CREBBP | Q92793 | 2/20 | 0.40 |
| ▸ | PGR | P06401 | 1/20 | 0.39 |
| ▸ | AR | P10275 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | AHR | P35869 | 1/20 | 0.36 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | HK1 | P19367 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | GALK1 | P51570 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1119036 | 0.78 | GAA (0.46) | BRD4CREBBPPGRNPC1KMT2A | |
| SCHEMBL31059284 | 0.75 | HTR5A (0.37) | BRD4CREBBPNPC1KMT2AAHR | |
| SCHEMBL23714201 | 0.75 | HTR5A (0.37) | BRD4CREBBPNPC1KMT2AAHR | |
| SCHEMBL23352920 | 0.72 | BRD4 (0.35) | BRD4CREBBPNPC1KMT2AAHR | |
| SCHEMBL7068997 | 0.72 | KMT2A (0.60) | BRD4CREBBPNPC1KMT2AAHR | |
| SCHEMBL30681584 | 0.71 | BRD4 (0.41) | BRD4CREBBPNPC1KMT2AAHR | |
| SCHEMBL5837737 | 0.69 | BRD4 (0.42) | BRD4CREBBPNPC1KMT2AAHR | |
| SCHEMBL30486500 | 0.69 | KDM4E (0.45) | BRD4CREBBPKDM4E | |
| SCHEMBL6773172 | 0.69 | BRD4 (0.42) | BRD4CREBBPNPC1KMT2AAHR | |
| SCHEMBL6959929 | 0.68 | BRD4 (0.35) | BRD4CREBBPNPC1KMT2AAHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101297077-A | Textiles treated with hindered amines | MILLIKEN & CO (US) | 2008-10-29 | — | — | CN | claimed |
| WO-2007050245-A2 | HINDERED AMINE TREATED TEXTILES | MILLIKEN & COMPANY (US) | 2007-05-03 | — | — | WO | claimed |
| US-20070092724-A1 | Hindered amine treated textiles | MILLIKEN & COMPANY | 2007-04-26 | — | — | US | claimed |
| US-20250354016-A1 | HALS AS ANTI-MICROBIAL ADDITIVES IN FREE-RADICAL SYSTEMS | ARKEMA FRANCE (FR) | 2025-11-20 | — | — | US | disclosed |
| EP-4536762-A1 | HALS AS ANTI-MICROBIAL ADDITIVES IN FREE-RADICAL SYSTEMS | ARKEMA FRANCE (FR) | 2025-04-16 | — | — | EP | disclosed |
| WO-2023237771-A1 | HALS AS ANTI-MICROBIAL ADDITIVES IN FREE-RADICAL SYSTEMS | ARKEMA FRANCE (FR) | 2023-12-14 | — | — | WO | disclosed |
| EP-4289907-A1 | HALS AS ANTI-MICROBIAL ADDITIVES IN FREE-RADICAL SYSTEMS | ARKEMA FRANCE (FR) | 2023-12-13 | — | — | EP | disclosed |
| US-9249157-B2 | Tricyclic heterocycle compounds | BRISTOL-MYERS SQUIBB COMPANY (US) | 2016-02-02 | — | — | US | disclosed |
| US-20150246930-A1 | TRICYCLIC HETEROCYCLE COMPOUNDS | BRISTOL-MEYERS SQUIBB COMPANY (US) | 2015-09-03 | — | — | US | disclosed |
| US-7998886-B2 | Hindered amine treated textiles | MILLIKEN & COMPANY (US) | 2011-08-16 | — | — | US | disclosed |
| US-7858539-B2 | Processes for generating halamine compounds on textile substrates to produce antimicrobial finish | MILLIKEN & COMPANY (US) | 2010-12-28 | — | — | US | disclosed |
| CN-101297077-A | Textiles treated with hindered amines | MILLIKEN & CO (US) | 2008-10-29 | — | — | CN | disclosed |
| US-20080248705-A1 | Processes for generating halamine compounds on textile substrates to produce antimicrobial finish | MILLIKEN & COMPANY | 2008-10-09 | — | — | US | disclosed |
| US-20070092724-A1 | Hindered amine treated textiles | MILLIKEN & COMPANY | 2007-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150246930-A1 | TRICYCLIC HETEROCYCLE COMPOUNDS | RCOR3, NR4A3, NCOA3 | BRD4 159/4885CREBBP 1187/4885PGR 523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.